Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Visual Acuity
100%
Endophthalmitis
55%
Cataract Surgery
43%
Injection
41%
Macular Edema
36%
Central Retinal Vein Occlusion
32%
Pars Plana Vitrectomy
32%
Retinal Detachment
31%
Retina Vein Occlusion
30%
Optical Coherence Tomography
28%
Intravitreal Administration
26%
Bevacizumab
25%
Hemiretinal Vein Occlusion
24%
Intraocular Pressure
23%
Diabetic Retinopathy
22%
Ophthalmology
22%
Vasculotropin
20%
Laser Coagulation
20%
Diabetic Macular Edema
20%
Proliferative Diabetic Retinopathy
19%
Best Corrected Visual Acuity
18%
Glaucoma
16%
Cataract
16%
Branch Retinal Vein Occlusion
15%
Triamcinolone Acetonide
15%
Clinical Trial
15%
Corticosteroid
14%
Clinical Feature
14%
Agents Acting on the Eye
14%
Vitrectomy
13%
Randomized Clinical Trials
13%
Ranibizumab
12%
Triamcinolone
11%
Implant
11%
Silicone Oil
11%
Visual Impairment
10%
Intraocular Lens
10%
Fluorescein
10%
Phacoemulsification
9%
Age Related Macular Degeneration
9%
Vitreoretinal Surgery
8%
Macular Hole
8%
Aflibercept
8%
Surgeon
8%
Vitreous
7%
Medical Record
7%
Neoplasm
7%
Antibiotics
7%
Bleeding
7%
Tamponade
7%
Keyphrases
Visual Acuity
75%
Retinal Vein Occlusion
56%
Endophthalmitis
51%
Macular Edema
39%
Cataract Surgery
38%
Diabetic Macular Edema
30%
Pars Plana Vitrectomy
29%
Intravitreal Injection
27%
Visual Acuity Outcome
27%
Age-related Macular Degeneration
25%
Optical Coherence Tomography
24%
Intravitreal Bevacizumab
23%
Proliferative Diabetic Retinopathy
22%
Bevacizumab
22%
Best-corrected Visual Acuity
20%
Randomized Clinical Trial
17%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
17%
Intravitreal Ranibizumab
16%
Central Subfield Thickness
15%
Clinical Features
15%
Aflibercept
15%
Visual Outcome
14%
Intravitreal
14%
Branch Retinal Vein Occlusion
12%
Anti-vascular Endothelial Growth Factor Therapy
12%
Retinal Detachment
12%
Intraocular Pressure
11%
Retina
11%
Corticosteroids
11%
Diabetic Retinopathy
10%
American Academy of Ophthalmology
10%
Retinoblastoma
10%
Rhegmatogenous Retinal Detachment
10%
Retinal Thickness
10%
Clinical Trials
10%
United States
10%
Vitreoretinal Surgery
9%
Medical Records
9%
Cataract
9%
Ophthalmology
9%
Early Treatment Diabetic Retinopathy Study
9%
Vision Loss
9%
Central Vein Occlusion
8%
Macular Hole Retinal Detachment
8%
Visual Function
8%
Panretinal Photocoagulation
8%
After Cataract
8%
Ranibizumab
8%
95% Confidence Interval
8%
Acute Onset
7%